LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

LLY

884.96

-0.04%↓

NVO

141.87

+0.6%↑

UNH

482.42

-0.43%↓

JNJ

148.65

+0.6%↑

MRK

130.24

+0.4%↑

Search

BeiGene Ltd ADR

Closed

Sector Healthcare

155.4 0.08

Overview

Share price change

24h

Current

Min

154.54

Max

156.77

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+56.91 upside

Dividends

By Dow Jones

Next Earnings

31 lip 2024

News Sentiment

By Acuity

80%

20%

328 / 369 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

BeiGene Ltd ADR Chart

Related News

23 kwi 2024, 14:58 UTC

Major Market Movers

BeiGene Shares Rise 7% After European Approval of Tislelizumab Cancer Treatment

13 mar 2024, 12:42 UTC

Major Market Movers

BeiGene Shares Rise on First Dosing of Brukinsa

8 maj 2024, 10:02 UTC

Earnings

BeiGene 1Q Loss/Shr 19c >BGNE

8 maj 2024, 10:01 UTC

Earnings

BeiGene 1Q Loss $251.2M >BGNE

8 maj 2024, 10:01 UTC

Earnings

BeiGene 1Q Rev $752M >BGNE

26 lut 2024, 11:01 UTC

Earnings

BeiGene 4Q Loss/Shr 27c >BGNE

26 lut 2024, 11:01 UTC

Earnings

BeiGene 4Q Rev $634.4M >BGNE

14 lis 2023, 04:24 UTC

Market Talk

BeiGene's Global Sales Outlook Brightens -- Market Talk

7 lis 2023, 02:44 UTC

Market Talk

BeiGene Likely to Post Solid 3Q Sales Growth -- Market Talk

2 sie 2023, 10:09 UTC

Earnings

BeiGene 2Q U.S. Sales of BRUKINSA Totaled $223.5M >BGNE

Peer Comparison

Price change

BeiGene Ltd ADR Forecast

Price Target

By TipRanks

56.91% upside

12 Months Forecast

Average 244.96 USD  56.91%

High 309 USD

Low 152 USD

Based on 7 Wall Street analysts offering 12 month price targets forBeiGene Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

5

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

151.685 / 156.09Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

328 / 369 Ranking in Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average